Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulse-Daylight Photodynamic Therapy for Actinic Keratoses
2015-003020-31Phase 4Completed
- Sponsor
- Department of Dermatology, Bispebjerg Hospital
- Start
- Jul 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of methyl aminolevulinate in actinic keratosis (AK), sponsored by Department of Dermatology, Bispebjerg Hospital. Primary endpoint: Reduction in erythema. Started Jul 2015; status: completed.
02
Drugs
methyl aminolevulinate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2015-003020-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003020-31.